Tumors can induce immunosuppression by promoting immunosuppressive cells to accumulate around the tumor immune microenvironment (TIME) [1] and suppress the activation of effector T lymphocytes by blocking immune checkpoints (i.e., PD-1 and CTLA-4), which leads to evasion of tumor immune surveillance and attack [2]. Here, CTLA4 is linked to neoplasm.